High Intensity Focused Ultrasound Therapy News 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.SonaCare Medical Paves the Way with the First HIFU Device Cleared by the FDA for Prostate Tissue Ablation - A Year in Review
CHARLOTTE, N.C., Oct. 5, 2016 -- (Healthcare Sales & Marketing Network) -- SonaCare Medical, leading developer and manufacturer of High Intensity Focused Ultrasound (HIFU) Technologies, reports over 40 acquisitions of Sonablate® technology since the d... Devices SonaCare Medical, Sonablate, HIFU (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 5, 2016 Category: Pharmaceuticals Source Type: news
Insightec inks ExAblate co-development deal with Siemens
Insightec said today it inked a collaborative strategic deal with Siemens Healthineers (NYSE:SI) to develop compatibility between Insightec’s Exablate Neuro system and Siemens Magnetom Aera and Skyra 1.5 Tesla and 3T clinical MRI systems.
The companies said the agreement will expand Siemens diagnostic imaging portfolio and will allow existing and future Siemens MRI customers access to the Exablate Neuro system.
“Our agreement with Siemens Healthineers will allow us to significantly expand Exablate Neuro’s market presence. Siemens has embraced our technology and together we will bring our therapy to sign...
Source: Mass Device - August 15, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Neurological InSightec Ltd Siemens Healthineers Source Type: news
MassDevice.com +5 | The top 5 medtech stories for July 11, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. FDA approves Insightec’s Exablate Neuro focused ultrasound device
The FDA said today that it approved the Exablate Neuro device made by Insightec for treating essential tremor in patients who don’t respond to drug therapy.
...
Source: Mass Device - July 11, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
FDA approves Insightec’s Exablate Neuro focused ultrasound device
The FDA said today that it approved the Exablate Neuro device made by Insightec for treating essential tremor in patients who don’t respond to drug therapy.
The Exablate Neuro device uses high-intensity, focused ultrasound to thermally ablate targeted tissue, guided by continuous magnetic resonance imaging; the procedure can be performed non-invasively through an intact skull.
Essential tremor can be treated with beta blockers or anti-convulsant drugs, but some patients don’t respond to drug treatment, the federal safety watchdog said. A surgical treatment called thalamotomy or deep-brain stimulation can also ...
Source: Mass Device - July 11, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Imaging Neurological Regulatory/Compliance InSightec Ltd Source Type: news
First Prostate Cancer Patients Treated with HIFU Technology
Cordell Nwokeji, MD and Don Berardinucci, MD perform first Sonablate HIFU treatments in Houston, Texas at Houston Metro Urology in partnership with HIFU Prostate Services (Source: Disabled World)
Source: Disabled World - May 25, 2016 Category: Disability Tags: Prostate Cancer Source Type: news
'Caution Optimism' for HIFU in Prostate Cancer
(MedPage Today) -- Radical treatment avoided for 2 years in 90% of patients (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 13, 2016 Category: Primary Care Source Type: news
'Cautious Optimism' for HIFU in Prostate Cancer
(MedPage Today) -- Radical treatment avoided for 2 years in 90% of patients (Source: MedPage Today Urology)
Source: MedPage Today Urology - May 13, 2016 Category: Urology & Nephrology Source Type: news
Prostate Cancer: French HIFU Study Adds to DebateProstate Cancer: French HIFU Study Adds to Debate
A French study used HIFU to perform hemiablation of the prostate in men with low- and intermediate-risk cancer, adding to the debate on how and when the approach should be used. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 11, 2016 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
New FDA-Approved Prostate 'Tool': Will You HIFU?New FDA-Approved Prostate 'Tool': Will You HIFU?
High-intensity focused ultrasound (HIFU) is approved for prostate ablation but not for the treatment of prostate cancer. Why? What now? Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 8, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
SonaCare, Invivo team up for HIFU ablation tracking
High-intensity focused ultrasound (HIFU) developer SonaCare Medical said it...Read more on AuntMinnie.comRelated Reading:
SonaCare lands FDA nod for HIFU system
SonaCare teams up with Invivo
CorTechs renews distribution deal with Invivo
SonaCare names CFO
iCAD and Invivo collaborate (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 6, 2016 Category: Radiology Source Type: news
SonaCare inks marketing deal with Philips’ Invivo biz for its UroNav software
SonaCare Medical said today it inked a marketing alliance deal with Royal Philips (NYSE:PHG) business Invivo to license its UroNav fusion software with its Sonablate planning system.
The new deal will allow clinicians to use the UroNav device to annotate and biopsy targeted prostate tissue and localize the tissue appropriate for ablation directly with its Sonablate software, Charlotte, N.C.-based SonaCare said.
“This is a major strategic partnership for SonaCare. Working together, Invivo and SonaCare are putting in place a broad product portfolio for performing advanced diagnostics, targeted ablation, and systematic ...
Source: Mass Device - May 5, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Urology Invivo Royal Philips SonaCare Medical Source Type: news
Edap looks to raise $11m in direct placement round
Edap (NSDQ:EDAP) said today it inked an agreement with institutional investors for the placement of 3.3 million shares at $3.50 a piece, bringing in an estimated $11.5 million for the company.
Investors in the round will receive warrants to purchase up to 3.3 million shares at an exercise price of $4.50 per share, exchangeable beginning 6 months from the date issued and for a period of 2 years after, Edap said.
The French company said it expects the offering to close on or around April 14. H.C. Wainwright & Co. acted as the exclusive placement agent for the round, according to an SEC filing.
Yesterday, EDAP said it su...
Source: Mass Device - April 7, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Oncology EDAP TMS SA Source Type: news
Edap seeks FDA nod for Focal One HIFU
Edap (NSDQ:EDAP) said today it submitted an application for FDA 510(k) clearance for its next-gen high-intensity focused ultrasound Focal One device designed to treat prostate cancer.
The company said the new submission comes following the FDA 510(k) clearance of its Ablatherm Robotic HIFU designed for the ablation of prostate tissue, which it won last November.
“We are pleased to submit our Focal One HIFU device file to the FDA to further our goal of making EDAP’s full range of HIFU products available to both urologists and patients in the U.S. There is a clear, growing demand from the worldwide urology community...
Source: Mass Device - April 6, 2016 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Oncology Regulatory/Compliance EDAP TMS SA Source Type: news
HIFU for Prostate Cancer
MIAMI. (Ivanhoe Newswire) -- A treatment that can remove prostate cancer while still preserving a man’s quality of life. It’s now available in the United States for the first time ever. It’s called high-intensity focused ultrasound, or HIFU. (Source: Medical Headlines From Ivanhoe.com)
Source: Medical Headlines From Ivanhoe.com - March 23, 2016 Category: Consumer Health News Source Type: news
